ACLS vs OGN · P/E 54, rev $1.02B vs P/E 3.4, rev $6.40B
Axcelis Technologies Inc (ACLS) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Axcelis Technologies Inc (ACLS) is a semiconductor equipment & materials company listed on NASDAQ.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported ACLS revenue for 2024-12-31 was $1.02B. Net income was $201.0M. Revenue was down 10.0% from 2023-12-31 to 2024-12-31. ACLS currently screens at market cap $5.39B and trailing P/E 54.5.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
ACLS currently screens at market cap $5.39B and trailing P/E 54.5. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the ACLS and OGN stock pages for the full models.
Not investment advice.